🇺🇸 FDA
Pipeline program

SODIUM CHLORIDE SOLUTION 0.9%, mRNA-1345

mRNA-1345-P201

Phase 2 small_molecule active

Quick answer

SODIUM CHLORIDE SOLUTION 0.9%, mRNA-1345 for Respiratory syncytial virus is a Phase 2 program (small_molecule) at Moderna Biotech Spain with 1 ClinicalTrials.gov record(s).

Program details

Company
Moderna Biotech Spain
Indication
Respiratory syncytial virus
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials